Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- Check5 days agoChange DetectedPage revision tag updated from v3.5.3 to v3.5.4, indicating a small metadata/formatting update rather than changes to study content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows an updated software release/revision identifier (“Revision: v3.5.3”) instead of the previous one (“Revision: v3.5.2”). This reflects a site version update rather than a change to the clinical study details.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded Revision: v3.5.2. Removed Revision: v3.5.0.SummaryDifference0.0%

- Check62 days agoChange Detected- Revision updated to v3.5.0, replacing the previous v3.4.3. - This appears to be a software/update change with no visible edits to study details or user-facing content.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check98 days agoChange DetectedMinimal site update detected: Revision: v3.4.2 was added and the government funding lapse notice was removed. No changes were made to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.